Unknown

Dataset Information

Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence.


ABSTRACT: The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), poses several challenges to clinicians, due to its unpredictable clinical course. The identification of laboratory biomarkers, specific cellular, and molecular mediators of immune response could contribute to the prognosis and management of COVID-19 patients. Of utmost importance is also the detection of differentially expressed genes, which can serve as transcriptomic signatures, providing information valuable to stratify patients into groups, based on the severity of the disease. The role of biomarkers such as IL-6, procalcitonin, neutrophil-lymphocyte ratio, white blood cell counts, etc. has already been highlighted in recently published studies; however, there is a notab

SUBMITTER: Papadopoulou G 

PROVIDER: S-EPMC8948624 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature